Neuronetics

Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003,[4] that develops non-invasive treatments for depression and other chronic psychiatric and neurological disorders based upon neuromodulation technology. 

Neuronetics, Inc.
Public
Traded asNASDAQ: STIM
Russell 2000 Index component
Founded2003
HeadquartersMalvern, PA, United States
Key people
Keith J. Sullivan
(President and CEO)[1][2]

Stephen Furlong (CFO)[1] Andrew Macan
(General counsel)[1]

Dan Guthrie
(Chief Commercial Officer)[3]
Number of employees
167
As of March 31, 2018[4]
Websiteneurostar.com

They manufacture a transcranial magnetic stimulation device.

References
  1. "Neuronetics Announces the Appointment of Keith J. Sullivan as President and Chief Executive Officer" (Press release). Neuronetics. Retrieved July 15, 2020.
  2. "Neuronetics names new CEO". Seeking Alpha. Retrieved July 15, 2020.
  3. "NeuroStar Executive Team". Neuronetics.
  4. "Neuronetics, Inc. (stim) IPO". NASDAQ.com.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.